Digene

Gen-Probe, Roche Prevail in Arbitration With Digene Concerning Human Papillomavirus Agreement

SAN DIEGO, April 1 /PRNewswire-FirstCall/ -- Gen-Probe (Nasdaq: GPRO ) announced today that the Company, along with its co-respondents F. Hoffmann-La Roche Ltd. and Roche Molecular Systems, Inc., has prevailed in its arbitration with Digene (now Qiagen) concerning the Company's supply and purcha...

Hologic Announces Second Quarter Fiscal 2009 Operating Results

...uit issued its ruling rejecting Qiagen's (formerly digene Corporation) appeal and affirming the judgment of ...ourt's ruling should end a patent lawsuit filed by digene in January of 2007 against Third Wave alleging infringement of a digene patent by Third Wave's HPV ASR product. "We are ob...

Gen-Probe Reports Financial Results for First Quarter 2009

...ced that the Company, along with its co-respondents F. Hoffmann-La Roche Ltd. and Roche Molecular Systems, Inc., had prevailed in its arbitration with digene (now Qiagen) concerning the Company's supply and purchase agreement with Roche for HPV products. Webcast Conference Call ...

Kaiser Permanente Data Provides Strong Evidence for Continued Value of Combined Pap and HPV Testing

...lomavirus (HPV). QIAGEN developed and markets the digene (R) HPV Test, a cervical cancer screening test tha...r its HPV detection in the study (also called the digene HPV Test) and conventional cytology for its Pap t...ted positive for high-risk HPV infection with the digene HPV Test, patients in the age segments of 30-34 y...

New Local TV Ad Campaign To Educate St. Louis Women About Cervical Cancer Prevention and HPV Testing

...or a new campaign to air its 30-second ad for the digene HPV Test on local TV stations starting today thro...ce of the virus itself. The FDA has approved the digene HPV Test for use together with the Pap test in wo...ies show that, on average, the combination of the digene HPV Test and the Pap identifies 95-100 percent of...

New Local TV Ad Campaign To Educate Memphis Women About Cervical Cancer Prevention and HPV Testing

...or a new campaign to air its 30-second ad for the digene HPV Test on local TV stations starting today thro...ce of the virus itself. The FDA has approved the digene HPV Test for use together with the Pap test in wo...ies show that, on average, the combination of the digene HPV Test and the Pap identifies 95-100 percent of...

Mexican Department of Public Health to Launch Screening for Papillomavirus, Cause of Cervical Cancer

...s an entirely preventable disease," said Peer Schatz, CEO of QIAGEN (Nasdaq: QGEN ; Frankfurt, Prime Standard: QIA), the company that developed the digene (R) HPV Test, which will be used in the SSA's program and is the only such test approved by the U.S. Food and Drug Administration. "The Mexican gover...

John H. Landon Joins LipoScience Board of Directors

...th total sales of $1 billion and over 5,000 employees. Mr. Landon recently served as Chairman of the Board of Cholestech Corporation and Director of digene Corporation. He currently is a member of the board for Christiana Care Health System and a member of the Board of Advisors for Water Street Healthcare...

Study Finds New Version of QIAGEN's HPV Test for Developing Countries Could Reduce Risk of Cervical Cancer by More than Half When Combined With Appropriate Treatment

...nd the world every year and kills more than 250,000 -- of which 80 percent are in developing countries. The High-Risk hc2 HPV DNA Test(R) developed by digene Corp. (now part of QIAGEN) is emerging as a standard of care for identifying women at risk. In the United States, HPV testing has been approved by the...

NEJM Report Finds HPV Test More Effective Than Pap in Determining Cervical Cancer Risk

...ly such test that is both CE-marked in Europe and approved by the U.S. Food and Drug Administration(1). The molecular diagnostic test was developed by digene Corp., now part of QIAGEN N.V. (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA). The performance of QIAGEN's HPV test has been validated in studies that...

Digene in Medical Technology

Landmark Study in The New England Journal of Medicine Shows HPV Testing Significantly Reduces Deaths from Cervical Cancer, Compared to other Methods Including Pap

...(Nasdaq: QGEN ; Frankfurt, Prime Standard: QIA) digene HPV Test, which detects high-risk types of human ...apture 2 (hc2) DNA testing technology (called the digene HPV Test). The study was conducted in the Maharas...N HPV screening technologies -- care HPV and the digene HPV Test -- are expected to play a key role in re...

Ending Cervical Cancer Featured at Summit; QIAGEN CEO Issues a Call to Global Women Leaders

... But we need help in assuring access to these medical advances for all women, and we welcome QIAGEN's commitment and leadership." In addition to its digene HPV Test, which QIAGEN distributes widely in the United States, Europe and elsewhere, the company is partnering with the non-profit organization PATH ...

Study Finds QIAGEN's HPV Test Offers Greater Long-term Protection From Cervical Disease Than the Pap

... woman had both the HPV test and a conventional Pap. The sensitivity of the digene HPV Test was 96 percent for disease detected in the first year - substantia...egies -- of which HPV testing is one of the most promising new tools. The digene HPV Test is marketed by QIAGEN N.V. (NASDAQ: QGEN; Frankfurt, Prime Standar...

Testing for Human Papillomavirus

...med association with cervical cancer development. digene also offers the hc2 HPV DNA Test, which differenti...m. Cervical specimens that can be tested with the digene tests include specimens collected with the digene Cervical Sampler/DNA Collection Device, biopsies c...

Digene in Medical Products

hc2 HPV DNA Test

Features:... The digene HPV Test offers the laboratory optimum clinical sensitivity for patient risk assessment...
Company:Digene Corporation

Hybrid Capture® 2 High-Risk HPV DNA Test®

Features:... The digene HPV Test offers the laboratory optimum clinical sensitivity for patient risk assessment...
Company:Digene Corporation

Digene in Biological News

Survey reveals women and doctors aren't talking about HPV

...o learn more about cervical cancer prevention visit www.arhp.org/cervicalcancer. The survey was supported by an unrestricted educational grant from digene Corporation. ...

Digene in Biological Technology

Third Wave responds to Digene patent lawsuit

Madison, Wis. - Responding to a lawsuit filed by Digene Corp. , Third Wave Technologies said it has not violated a patent covering a single and rare type of the human papilloma virus (HPV) and would continue to develop products to detect high-risk infections. The lawsuit alleges that Thir...

Third Wave files countersuit vs. Digene in patent case

Madison, Wis . - Third Wave Technologies of Madison has filed an anti-trust countersuit in response to the recent patent lawsuit brought against it by Digene Corp . The countersuit was filed with the U.S. District Court for the Western District of Wisconsin in Madison, where the case is be...

QIAGEN and Chittaranjan National Cancer Institute Partner to Establish First Large-Scale Cervical Cancer Screening Program in Kolkata

...vical cancers and deaths. QIAGEN's HPV test platform -- known as the digene HPV Test -- uses advanced molecular diagnostic technologies to identify the... of molecular diagnostic tests available worldwide. This panel includes the digene HPV Test, which is regarded as the "gold standard" in testing for high-risk...

QIAGEN Welcomes 3,000th Employee in 20th year of U.S. Operations

...0 million. Over the past 20 years, QIAGEN has invested more than $2 billion in the U.S., including its $1.6 billion merger with Gaithersburg, MD based digene Corp. in 2007. According to Douglas Liu, Vice President of Global Operations and member of the company's Global Executive Committee, economic...

Micromet, Inc. Elects Joseph P. Slattery to Board of Directors

...nt and Chief Financial Officer of Digene Corporation, and left that position following the acquisition of Digene by Qiagen in July 2007. He had joined digene in 1996 as its Controller prior to its initial public offering, assumed the position of Senior Vice President of Finance and Information Systems in 20...

Third Wave agrees to drop Chiron, Bayer patent lawsuits

...ompany's HCV patent after evaluating the cost of the license versus the cost of continuing to litigate the suit. The company reached an agreement with digene Corp. in January under which the companies agreed not to bring suit over human papilloma virus, or HPV, patents against one another for one year. T...